Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study

United Kingdom Collaborative HIV Cohort Study, Katherine J Lee, David Dunn, Richard Gilson, Kholoud Porter, Loveleen Bansi, Teresa Hill, Andrew N Phillips, Caroline A Sabin, Achim Schwenk, Clifford Leen, Valerie Delpech, Jane Anderson, Brian Gazzard, Margaret Johnson, Philippa Easterbrook, John Walsh, Martin Fisher, Chloe Orkin

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

To describe the time from first viral rebound on highly active antiretroviral therapy to first treatment change, identify factors associated with more rapid switching, and investigate whether treatment changes are in line with treatment guidelines.
Original languageEnglish
Pages (from-to)1943-50
Number of pages8
JournalAIDS
Volume22
Issue number15
DOIs
Publication statusPublished - 1 Oct 2008

Keywords / Materials (for Non-textual outputs)

  • Adult
  • Anti-HIV Agents
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • Cohort Studies
  • Drug Resistance, Viral
  • Female
  • Guideline Adherence
  • HIV Infections
  • Humans
  • Male
  • Practice Guidelines as Topic
  • Viral Load

Fingerprint

Dive into the research topics of 'Treatment switches after viral rebound in HIV-infected adults starting antiretroviral therapy: multicentre cohort study'. Together they form a unique fingerprint.

Cite this